Lifevantage Corporation (LFVN) - Total Liabilities
Based on the latest financial reports, Lifevantage Corporation (LFVN) has total liabilities worth $28.52 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Lifevantage Corporation to see how much of total assets are deployed in long-term investments.
Lifevantage Corporation - Total Liabilities Trend (1997–2026)
This chart illustrates how Lifevantage Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Lifevantage Corporation total assets.
Lifevantage Corporation Competitors by Total Liabilities
The table below lists competitors of Lifevantage Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩22.80 Billion |
|
PolyPid
NASDAQ:PYPD
|
USA | $11.33 Million |
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
USA | $2.49 Million |
|
Daemyung Sonoseason Co.Ltd
KQ:007720
|
Korea | ₩54.13 Billion |
|
Asetek A/S
F:A31
|
Germany | €35.78 Million |
|
MAIA Biotechnology Inc.
NYSE MKT:MAIA
|
USA | $7.56 Million |
|
Novonix Ltd
AU:NVX
|
Australia | AU$125.86 Million |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
USA | $132.00K |
Liability Composition Analysis (1997–2026)
This chart breaks down Lifevantage Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See LFVN equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifevantage Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifevantage Corporation (1997–2026)
The table below shows the annual total liabilities of Lifevantage Corporation from 1997 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | $28.52 Million | -23.57% |
| 2025-06-30 | $37.32 Million | +8.77% |
| 2024-06-30 | $34.31 Million | +9.00% |
| 2023-06-30 | $31.47 Million | -19.69% |
| 2022-06-30 | $39.19 Million | -6.52% |
| 2021-06-30 | $41.92 Million | +63.62% |
| 2020-06-30 | $25.62 Million | -8.73% |
| 2019-06-30 | $28.07 Million | -3.84% |
| 2018-06-30 | $29.20 Million | -4.97% |
| 2017-06-30 | $30.72 Million | -19.42% |
| 2016-06-30 | $38.13 Million | +1.53% |
| 2015-06-30 | $37.55 Million | -24.91% |
| 2014-06-30 | $50.01 Million | +132.18% |
| 2013-06-30 | $21.54 Million | +32.59% |
| 2012-06-30 | $16.24 Million | -51.23% |
| 2011-06-30 | $33.31 Million | +48.68% |
| 2010-06-30 | $22.40 Million | +78.22% |
| 2009-06-30 | $12.57 Million | +810.99% |
| 2008-06-30 | $1.38 Million | +14.90% |
| 2007-06-30 | $1.20 Million | -44.49% |
| 2006-06-30 | $2.16 Million | +150.03% |
| 2005-06-30 | $865.20K | +5878.85% |
| 2004-06-30 | $14.47K | +113.59% |
| 2003-06-30 | $6.78K | +409.78% |
| 2002-06-30 | $1.33K | -94.46% |
| 2000-06-30 | $24.00K | -84.63% |
| 1999-06-30 | $156.18K | -23.05% |
| 1998-06-30 | $202.97K | +13.50% |
| 1997-06-30 | $178.82K | -- |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Om… Read more